https://www.taxtmi.com/caselaws?id=100385 For valuation of a captively consumed bulk drug, the relevant price could be taken from contemporaneous sales rather than an earlier lower price based on scattered sales over several years. Because there was no prior contract or established quantity-based discount arrangement showing that the parties contemplated an aggregated supply, each sale had to be assessed on its own terms. The bulk drug being used captively in manufacture of an exempt medicament, valuation fell under Rule 6(1)(b) of the Central Excise Valuation Rules, and the contemporaneous sale prices were properly treated as the correct basis. en-us Mon, 13 Aug 2001 00:00:00 +0530 Wed, 01 Feb 2012 12:38:29 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=100385 For valuation of a captively consumed bulk drug, the relevant price could be taken from contemporaneous sales rather than an earlier lower price based on scattered sales over several years. Because there was no prior contract or established quantity-based discount arrangement showing that the parties contemplated an aggregated supply, each sale had to be assessed on its own terms. The bulk drug being used captively in manufacture of an exempt medicament, valuation fell under Rule 6(1)(b) of the Central Excise Valuation Rules, and the contemporaneous sale prices were properly treated as the correct basis. Case-Laws Central Excise Mon, 13 Aug 2001 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=100385